Published in Blood on May 01, 1986
A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J Cell Biol (1987) 1.88
Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J Clin Invest (1991) 1.47
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest (1990) 1.10
Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest (1992) 1.09
Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci U S A (1990) 7.44
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med (1997) 6.13
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32
Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature (1984) 5.10
Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N Engl J Med (1978) 4.34
Leukocyte oxidase: defective activity in chronic granulomatous disease. Science (1967) 4.25
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev (2000) 3.24
Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc Natl Acad Sci U S A (1993) 3.09
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev (1996) 2.77
Globin chain synthesis in the alpha thalassemia syndromes. J Clin Invest (1969) 2.46
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest (1984) 2.43
The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. Cell (1979) 2.41
Treatment of Cooley's anemia. Blood (1990) 2.40
Disorders of phagocytic cell function. Prog Hematol (1971) 2.37
Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature (1986) 2.36
Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J Exp Med (1978) 2.33
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem (1998) 2.21
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood (1989) 2.13
Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. J Clin Invest (1969) 2.11
Hematopoietic growth factors. J Clin Invest (1987) 2.11
Patterns of histone variant synthesis can distinguish G0 from G1 cells. Cell (1982) 2.08
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest (1970) 2.04
Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet (1986) 2.04
Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am J Med (1966) 2.03
Opportunities for medical research in the 21st century. JAMA (2001) 2.01
Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A (1979) 1.94
Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. Science (1985) 1.86
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Antenatal diagnosis of haematological disorders--'1978'. Clin Haematol (1978) 1.78
Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest (1986) 1.76
Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest (1971) 1.72
Prenatal diagnosis of hemoglobinopathies. A review of 15 cases. N Engl J Med (1976) 1.69
Antenatal diagnosis of thalassaemia major. Br Med J (1978) 1.64
A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother (1997) 1.63
Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. J Clin Invest (1970) 1.59
Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med (1984) 1.54
Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. Exp Hematol (1992) 1.50
Stages in the incorporation of fatty acids into red blood cells. J Clin Invest (1968) 1.49
Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science (1991) 1.48
Diamond-Blackfan anemia. Natural history and sequelae of treatment. Medicine (Baltimore) (1996) 1.46
Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood (1975) 1.46
Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci U S A (1999) 1.42
A revived opportunity for fetal research. Nature (1993) 1.40
Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol (1999) 1.40
Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med (1976) 1.40
An orally active iron chelator. N Engl J Med (1995) 1.40
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
Congenital hemolytic anemia with high-sodium, low-potassium red cells. Studies of three generations of a family with a new variant. N Engl J Med (1969) 1.37
Temperature-induced variations in the surface topology of cultured lymphocytes are revealed by scanning electron microscopy. Proc Natl Acad Sci U S A (1973) 1.37
Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest (1987) 1.36
Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. J Clin Invest (1985) 1.36
Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. Blood (1974) 1.36
Congenital hemolytic anemia with high sodium, low potassium red cells. I. Studies of membrane permeability. N Engl J Med (1968) 1.36
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med (1978) 1.35
Diamond-Blackfan anemia. Curr Opin Hematol (2000) 1.34
Cation permeability alterations during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells. Blood (1978) 1.34
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia. J Clin Invest (1978) 1.33
The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem (1998) 1.31
Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med (1985) 1.30
The common tetratricopeptide repeat acceptor site for steroid receptor-associated immunophilins and hop is located in the dimerization domain of Hsp90. J Biol Chem (1999) 1.30
Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science (1988) 1.26
Fetal erythropoiesis following bone marrow transplantation. Blood (1976) 1.26
Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25
Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia. J Clin Invest (1972) 1.25
Characterization of an inducible, epidermal-specific knockout system: differential expression of lacZ in different Cre reporter mouse strains. Genesis (2000) 1.23
Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. J Exp Med (1999) 1.22
THE TURNOVER OF HEMOGLOBINS A, F, AND A(2) IN THE PERIPHERAL BLOOD OF THREE PATIENTS WITH THALASSEMIA. J Clin Invest (1963) 1.20
Ribosomes from Rauscher leukemia virus-infected cells and their response to Rauscher viral RNA and polyuridylic acid. Biochim Biophys Acta (1973) 1.19
The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood (1997) 1.18
Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med (1987) 1.17
Changes in histone H3 composition and synthesis pattern during lymphocyte activation. Biochemistry (1983) 1.17
Beta thalassemia and translation of globin messenger RNA. Proc Natl Acad Sci U S A (1971) 1.16
Gamma-beta thalassemia: a cause of hemolytic disease of the newborn. N Engl J Med (1972) 1.16
Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol (1995) 1.15
Transfusion management of sickle cell disease. Blood (1993) 1.14
Congenital hemolytic anemia associated with dehydrated erythrocytes and increased potassium loss. N Engl J Med (1974) 1.13
Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. Blood (2001) 1.12
New approaches to the transfusion management of thalassemia. Blood (1980) 1.12
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet (1982) 1.10
High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation. Proc Soc Exp Biol Med (1997) 1.10
Influence of hemoglobin precipitation on erythrocyte metabolism in alpha and beta thalassemia. J Clin Invest (1969) 1.09
Sodium and potassium concentration and transmembrane fluxes in leukocytes. Blood (1974) 1.08
Acquired aplastic anemias: pathophysiology and treatment. Adv Intern Med (1982) 1.07
Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. J Clin Invest (1971) 1.07
Hemoglobin synthesis in human BFU-E and CFU-E-derived erythroid colonies. Blood (1979) 1.06
Detection of the sickle gene in the human fetus. Potential for intrauterine diagnosis of sickle-cell anemia. N Engl J Med (1972) 1.06